CLL | Tumor

CURE’s Chronic Lymphocytic Leukemia (CLL) page features the latest cancer news and updates on CLL Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in chronic lymphocytic leukemia.

DKMS Donates 12,000 Buccal Swabs to Memorial Sloan Kettering for COVID-19 Testing

May 5th 2020, 12:26am

Article

International Nonprofit Provides 126K+ Swabs Globally to Help Fight Virus

COVID-19's Impact on How Patients with CLL, Myeloma Have Received Treatment

May 4th 2020, 10:00pm

Article

In the first installment of CURE®’s inaugural webinar series, “Hear from the Experts: COVID-19 & Cancer Care for Patients”, Dr. Farukh Awan addresses how the new coronavirus has impacted patient care for those diagnosed with chronic lymphocytic leukemia and myeloma.

How Patients with Chronic Lymphocytic Leukemia Are Equipped to Handle the COVID-19 Pandemic

May 4th 2020, 5:00pm

Video

Patients with chronic lymphocytic leukemia are at risk for the worst of COVID-19 symptoms, but going on the cancer journey has prepared them for the pandemic.

How Social Distancing Helped Create a Sense of Community Among Some Patients with CLL

May 1st 2020, 1:00am

Video

Social distancing measures are keeping people apart, but that hasn't stopped some patients with CLL from finding a new sense of community.

How COVID-19 Has Impacted Clinical Trials for Chronic Lymphocytic Leukemia

April 30th 2020, 1:11am

Video

The COVID-19 Pandemic has changed immediate treatment for patients with chronic lymphocytic leukemia, but it is also impacting the clinical trials looking to improve the future treatment for these patients.

5 Cancer-Related FDA Approvals Patients May Have Missed

April 27th 2020, 7:00pm

Article

Dr. Richard Pazdur, director of the Food and Drug Administration’s Oncology Center of Excellence, has noted that the agency is committed to expediting oncology drug development despite the challenges posed by the COVID-19 pandemic.

FDA Approves Imbruvica, Rituxan Combination in Previously Untreated Patients with CLL and SLL

April 21st 2020, 11:52pm

Article

The Food and Drug Administration, under its global Project Orbis, approved the combination of Imbruvica and Rituxan for patients with CLL and SLL.

Calquence Could Offer Treatment for Chronic Lymphocytic Leukemia with Fewer Side Effects

April 20th 2020, 10:00pm

Article

Calquence (acalabrutinib) may be a safe and effective treatment option for patients with relapsed or refractory chronic lymphocytic leukemia, according to the updated phase 2 results of an ongoing study.

New Prognostic Tool Helps Patients With Leukemia Anticipate Care Needs

April 17th 2020, 10:00pm

Article

First validated prognostic score offers valuable insights for patients with chronic lymphocytic leukemia who are prescribed active surveillance.

Treatment Advances in Chronic Lymphocytic Leukemia

April 8th 2020, 7:00pm

Article

Bruton tyrosine kinase (BTK) inhibitors and other new drugs are improving outcomes for patients with CLL.